TrkA-mediated endocytosis of p75-CTF prevents cholinergic neuron death upon γ-secretase inhibition

Autor: Lucía Chávez-Gutiérrez, Raquel Comaposada-Baró, María Luisa Franco, Marçal Vilar, Juan J Escribano-Saiz, Irmina García-Carpio
Přispěvatelé: Ministerio de Economía y Competitividad (España), Generalitat Valenciana, Fondation Recherche Alzheimer, Research Foundation - Flanders, Vilar, Marçal [0000-0002-9376-6544], Vilar, Marçal
Rok vydání: 2021
Předmět:
Life Sciences & Biomedicine - Other Topics
0301 basic medicine
C-JUN
Health
Toxicology and Mutagenesis

Amino Acid Motifs
Plant Science
Tropomyosin receptor kinase A
Ligands
Receptor
Nerve Growth Factor

INTRAMEMBRANE PROTEOLYSIS
0302 clinical medicine
Low-affinity nerve growth factor receptor
Cycloheximide
GENE-EXPRESSION
Basal forebrain
Cell Death
Ecology
Chemistry
LINKED DIMERS
Neurodegeneration
Cholinergic Neurons
Endocytosis
Cell biology
P75 NEUROTROPHIN RECEPTOR
Life Sciences & Biomedicine
Research Article
Protein Binding
endocrine system
Programmed cell death
BASAL FOREBRAIN NEURONS
MAP Kinase Signaling System
Notch signaling pathway
Biochemistry
Genetics and Molecular Biology (miscellaneous)

03 medical and health sciences
Alzheimer Disease
medicine
Humans
Protein Interaction Domains and Motifs
Receptor
trkA

Cholinergic neuron
Biology
Science & Technology
NERVE GROWTH-FACTOR
medicine.disease
P75(NTR)
LIPID RAFTS
030104 developmental biology
nervous system
COGNITIVE DECLINE
Proteolysis
Cholinergic
Amyloid Precursor Protein Secretases
Protein Multimerization
030217 neurology & neurosurgery
Zdroj: Digital.CSIC. Repositorio Institucional del CSIC
instname
Life Science Alliance
ISSN: 2017-8409
Popis: 20 páginas, 8 figuras
γ-secretase inhibitors (GSI) were developed to reduce the generation of Aβ peptide to find new Alzheimer's disease treatments. Clinical trials on Alzheimer's disease patients, however, showed several side effects that worsened the cognitive symptoms of the treated patients. The observed side effects were partially attributed to Notch signaling. However, the effect on other γ-secretase substrates, such as the p75 neurotrophin receptor (p75NTR) has not been studied in detail. p75NTR is highly expressed in the basal forebrain cholinergic neurons (BFCNs) during all life. Here, we show that GSI treatment induces the oligomerization of p75CTF leading to the cell death of BFCNs, and that this event is dependent on TrkA activity. The oligomerization of p75CTF requires an intact cholesterol recognition sequence (CRAC) and the constitutive binding of TRAF6, which activates the JNK and p38 pathways. Remarkably, TrkA rescues from cell death by a mechanism involving the endocytosis of p75CTF. These results suggest that the inhibition of γ-secretase activity in aged patients, where the expression of TrkA in the BFCNs is already reduced, could accelerate cholinergic dysfunction and promote neurodegeneration.
This study was supported by the Spanish Minister of Economy and Competitiveness grant SAF2017-84096-R and by the Generalitat Valenciana 2018-55 to M Vilar. I García-Carpio was supported by an Formación de Personal Investigador (FPI) pre-doctoral fellowship (BFU2013/42746-P) and a mobility grant (EEBB-I-15-10278) from the Spanish Minister of Economy and Competitiveness. This work was funded by the Stichting Alzheimer Onderzoek (S16013) and the Fonds voor Wetenschappelijk Onderzoek or Flanders Research Foundation (FWO) research project (G0B2519N) to L Chavez-Gutiérrez
Databáze: OpenAIRE